The influence of photodynamic therapy on the immune response.

[1]  Michael R Hamblin,et al.  Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. , 2005, Photodiagnosis and photodynamic therapy.

[2]  F. Guillemin,et al.  Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy. , 2005, Bioorganic & medicinal chemistry.

[3]  B. Prakken,et al.  Heat-shock proteins induce T-cell regulation of chronic inflammation , 2005, Nature Reviews Immunology.

[4]  A. Palucka,et al.  Dendritic cells as therapeutic vaccines against cancer , 2005, Nature Reviews Immunology.

[5]  T. Kiesslich,et al.  Apoptosis following photodynamic tumor therapy: induction, mechanisms and detection. , 2005, Current pharmaceutical design.

[6]  Hui Zhang,et al.  Platelet activation leads to activation and propagation of the complement system , 2005, The Journal of experimental medicine.

[7]  Michael R Hamblin,et al.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death. , 2005, Photodiagnosis and photodynamic therapy.

[8]  J. Svennilson.  Novel approaches in GVHD therapy , 2005, Bone Marrow Transplantation.

[9]  F. Locatelli,et al.  Update on extracorporeal photochemotherapy for graft-versus-host disease treatment , 2005, Bone Marrow Transplantation.

[10]  A Tanew,et al.  Topical aminolaevulinic acid‐based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer‐blinded study , 2005, The British journal of dermatology.

[11]  Mladen Korbelik,et al.  Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. , 2005, Cancer research.

[12]  F. Ronchese,et al.  Dendritic Cells Loaded with Stressed Tumor Cells Elicit Long-Lasting Protective Tumor Immunity in Mice Depleted of CD4+CD25+ Regulatory T Cells1 , 2005, The Journal of Immunology.

[13]  N. Bhardwaj,et al.  Apoptotic cells at the crossroads of tolerance and immunity. , 2005, Current topics in microbiology and immunology.

[14]  Hong Liu,et al.  Enhancement of Laser Cancer Treatment by a Chitosan-derived Immunoadjuvant¶ , 2005, Photochemistry and photobiology.

[15]  D. Nowis,et al.  Light and Light Sources for Pdt Direct Tumor Damage Mechanisms of Photodynamic Therapy , 2005 .

[16]  J. Witztum,et al.  Apoptotic Cells with Oxidation-specific Epitopes Are Immunogenic and Proinflammatory , 2004, The Journal of experimental medicine.

[17]  G. Trinchieri,et al.  Interleukin‐10 in viral diseases and cancer: exiting the labyrinth? , 2004, Immunological reviews.

[18]  M. Smyth,et al.  Cytokines in cancer immunity and immunotherapy , 2004, Immunological reviews.

[19]  Michael R Hamblin,et al.  Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. , 2004, Photodiagnosis and photodynamic therapy.

[20]  S. Adams,et al.  Manipulating dendritic cell biology for the active immunotherapy of cancer. , 2004, Blood.

[21]  Heinz Baumann,et al.  Photodynamic Therapy Causes Cross-linking of Signal Transducer and Activator of Transcription Proteins and Attenuation of Interleukin-6 Cytokine Responsiveness in Epithelial Cells , 2004, Cancer Research.

[22]  Michael R Hamblin,et al.  Photodynamic Therapy Targeted to Pathogens , 2004, International journal of immunopathology and pharmacology.

[23]  Mladen Korbelik,et al.  Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[24]  P. Agostinis,et al.  Regulatory pathways in photodynamic therapy induced apoptosis , 2004, Photochemical and Photobiological Sciences.

[25]  P. Mróz,et al.  Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells , 2004, Clinical Cancer Research.

[26]  Joan W. Miller,et al.  Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2. , 2004, Archives of ophthalmology.

[27]  A. Jakubowska,et al.  CpG Immunostimulatory Oligodeoxynucleotide 1826 Enhances Antitumor Effect of Interleukin 12 Gene-Modified Tumor Vaccine in a Melanoma Model in Mice , 2004, Clinical Cancer Research.

[28]  Michael R Hamblin,et al.  Macrophage-Targeted Photodynamic Therapy , 2004, International journal of immunopathology and pharmacology.

[29]  A. Mazzoni,et al.  Controlling the Toll road to dendritic cell polarization , 2004, Journal of leukocyte biology.

[30]  Qiang Liu,et al.  Photodynamic therapy upregulates expression of Mac-1 and generation of leukotriene B(4) by human polymorphonuclear leukocytes. , 2004, Oral oncology.

[31]  M. Miyasaka,et al.  Lymphocyte trafficking across high endothelial venules: dogmas and enigmas , 2004, Nature Reviews Immunology.

[32]  R. Schreiber,et al.  The three Es of cancer immunoediting. , 2004, Annual review of immunology.

[33]  Barbara W. Henderson,et al.  Choice of Oxygen-Conserving Treatment Regimen Determines the Inflammatory Response and Outcome of Photodynamic Therapy of Tumors , 2004, Cancer Research.

[34]  H. Groux,et al.  Specialization in tolerance: innate CD4+CD25+ versus acquired TR1 and TH3 regulatory T cells.1 , 2004, Transplantation.

[35]  G. V. van Dongen,et al.  Photosensitizer-antibody conjugates for detection and therapy of cancer. , 2004, Advanced drug delivery reviews.

[36]  Q. Peng,et al.  Effects of Photodynamic Therapy on Tumor Stroma , 2004, Ultrastructural pathology.

[37]  D. Carbone,et al.  Tumor-host immune interactions and dendritic cell dysfunction. , 2004, Advances in cancer research.

[38]  G. Cavaletti,et al.  Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells. , 2004, Journal of biological regulators and homeostatic agents.

[39]  K. König,et al.  Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo , 2004, Archives of Dermatological Research.

[40]  J. Levy,et al.  Suppressor deletion therapy: selective elimination of T suppressor cells in vivo using a hematoporphyrin conjugated monoclonal antibody permits animals to reject syngeneic tumor cells , 2004, Cancer Immunology, Immunotherapy.

[41]  J. Gołąb,et al.  Natural mechanisms protecting against cancer. , 2003, Immunology letters.

[42]  A. Thomson,et al.  Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction , 2003, Immunological reviews.

[43]  D. Pardoll,et al.  Does the immune system see tumors as foreign or self? , 2003, Annual review of immunology.

[44]  P. Kuppen,et al.  Immunological Aspects of Photodynamic Therapy of Liver Tumors in a Rat Model for Colorectal Cancer¶ , 2003, Photochemistry and photobiology.

[45]  J. Gołąb,et al.  Interleukin 12-based immunotherapy improves the antitumor effectiveness of a low-dose 5-Aza-2'-deoxycitidine treatment in L1210 leukemia and B16F10 melanoma models in mice. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[46]  S. Hahn,et al.  Elevated Serum Cytokine Levels in Mesothelioma Patients Who Have Undergone Pleurectomy or Extrapleural Pneumonectomy and Adjuvant Intraoperative Photodynamic Therapy¶ , 2003, Photochemistry and photobiology.

[47]  D. Fraker,et al.  Intraperitoneal Photodynamic Therapy Causes a Capillary-Leak Syndrome , 2003, Annals of Surgical Oncology.

[48]  B W Henderson,et al.  Role of cytokines in photodynamic therapy-induced local and systemic inflammation , 2003, British Journal of Cancer.

[49]  C. Nicchitta.  Re-evaluating the role of heat-shock protein–peptide interactions in tumour immunity , 2003, Nature Reviews Immunology.

[50]  M. Korbelik,et al.  Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours , 2003, British Journal of Cancer.

[51]  Fritz Sieber,et al.  Preferential inactivation of paediatric solid tumour cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous haematopoietic stem cell grafts. , 2003, Journal of photochemistry and photobiology. B, Biology.

[52]  P. Ward,et al.  Complement in ischemia reperfusion injury. , 2003, The American journal of pathology.

[53]  P. Mróz,et al.  Antitumor Effects of Photodynamic Therapy Are Potentiated by 2-Methoxyestradiol , 2003, The Journal of Biological Chemistry.

[54]  P. Kuppen,et al.  The immunological consequences of photodynamic treatment of cancer, a literature review. , 2003, Immunobiology.

[55]  R. Pottier,et al.  New directions in photodynamic therapy. , 2002, Cellular and molecular biology.

[56]  H. Schluesener,et al.  Release of regulators of angiogenesis following Hypocrellin-A and -B photodynamic therapy of human brain tumor cells. , 2002, Biochemical and biophysical research communications.

[57]  M. Korbelik,et al.  Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. , 2002, Cancer letters.

[58]  M. Korbelik,et al.  Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumours , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[59]  H. Lui,et al.  Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques. , 2002, The Journal of investigative dermatology.

[60]  N. Chao,et al.  Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process. , 2002, Blood.

[61]  A. Curnow,et al.  The role of reperfusion injury in photodynamic therapy with 5-aminolaevulinic acid – a study on normal rat colon , 2002, British Journal of Cancer.

[62]  Barbara W Henderson,et al.  Generation of effective antitumor vaccines using photodynamic therapy. , 2002, Cancer research.

[63]  B. Dupas,et al.  Extracorporeal photochemotherapy for secondary chronic progressive multiple sclerosis: a pilot study , 2002, Photodermatology, photoimmunology & photomedicine.

[64]  Laurence Zitvogel,et al.  Antigen presentation and T cell stimulation by dendritic cells. , 2002, Annual review of immunology.

[65]  B. Henderson,et al.  IL-10 Does not Play a Role in Cutaneous Photofrin® Photodynamic Therapy-induced Suppression of the Contact Hypersensitivity Response¶ , 2001 .

[66]  B. Krammer,et al.  Vascular effects of photodynamic therapy. , 2001, Anticancer research.

[67]  M. Korbelik,et al.  Induction of Systemic Neutrophil Response in Mice by Photodynamic Therapy of Solid Tumors¶ , 2001, Photochemistry and photobiology.

[68]  B. McManus,et al.  Fas ligand and TRAIL augment the effect of photodynamic therapy on the induction of apoptosis in JURKAT cells. , 2001, International immunopharmacology.

[69]  J. Usuda,et al.  Increased cytotoxic effects of photodynamic therapy in IL‐6 gene transfected cells via enhanced apoptosis , 2001, International journal of cancer.

[70]  M. Korbelik,et al.  Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line , 2001, International journal of cancer.

[71]  A. Porwit,et al.  Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response. , 2001, Acta dermato-venereologica.

[72]  M. Korbelik,et al.  Interaction Between Photodynamic Therapy and BCG Immunotherapy Responsible for the Reduced Recurrence of Treated Mouse Tumors¶ , 2001 .

[73]  H. Oppelaar,et al.  Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy. , 2001, Cancer research.

[74]  B W Henderson,et al.  Activation of the IL-10 Gene Promoter Following Photodynamic Therapy of Murine Keratinocytes¶ , 2001, Photochemistry and photobiology.

[75]  H. S. de Bruijn,et al.  Effect of thrombocytopenia on the efficacy of Photofrin-based photodynamic therapy in vivo , 2001, European Conference on Biomedical Optics.

[76]  S. Jee,et al.  Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency , 2001, Oncogene.

[77]  G Corbitt,et al.  Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. , 2001, Cancer research.

[78]  N. Brasseur,et al.  Eradication of Multiple Myeloma and Breast Cancer Cells by TH9402-mediated Photodynamic Therapy: Implication for Clinical Ex Vivo Purging of Autologous Stem Cell Transplants¶ , 2000, Photochemistry and photobiology.

[79]  K. Sano,et al.  Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma , 2000, Cancer Immunology, Immunotherapy.

[80]  H. Greinix,et al.  Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study. , 2000, Blood.

[81]  M. Korbelik,et al.  Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy , 2000, British Journal of Cancer.

[82]  A. Dabrowska,et al.  Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF , 2000, British Journal of Cancer.

[83]  A. Wells,et al.  Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view. , 2000, Immunology today.

[84]  J. Levy,et al.  IL-10 Contributes to the Inhibition of Contact Hypersensitivity in Mice Treated with Photodynamic Therapy , 2000, The Journal of Immunology.

[85]  J. Piette,et al.  Nuclear factor-κB activation by the photochemotherapeutic agent verteporfin , 2000 .

[86]  T. Wieman,et al.  Vascular damage after photodynamic therapy of solid tumors: a view and comparison of effect in pre-clinical and clinical models at the University of Louisville. , 2000, In vivo.

[87]  B. McManus,et al.  Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin. , 2000, Blood.

[88]  François Guillemin,et al.  Foscan® (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-α-mediated cytolytic activity , 1999, British Journal of Cancer.

[89]  L. Villeneuve.  Ex vivo photodynamic purging in chronic myelogenous leukaemia and other neoplasias with rhodamine derivatives , 1999, Biotechnology and applied biochemistry.

[90]  A. Cincotta,et al.  Role of the Immune System in Mediating the Antitumor Effect of Benzophenothiazine Photodynamic Therapy , 1999, Photochemistry and photobiology.

[91]  J. Gołąb,et al.  Antitumor effects of interleukin-12 in pre-clinical and early clinical studies (Review). , 1999, International journal of molecular medicine.

[92]  M. Korbelik,et al.  Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. , 1999, Cancer research.

[93]  H. Oppelaar,et al.  Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy. , 1999, Cancer research.

[94]  M. Korbelik,et al.  Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. , 1999, Cancer letters.

[95]  A. Oseroff,et al.  The Anatomic Site of Photodynamic Therapy is a Determinant for Immunosuppression in a Murine Model , 1999, Photochemistry and photobiology.

[96]  M. Obochi,et al.  Photodynamic Alteration of the Surface Receptor Expression Pattern of Murine Splenic Dendritic Cells , 1999, Scandinavian journal of immunology.

[97]  J. Piette,et al.  Pyropheophorbide-a Methyl Ester-mediated Photosensitization Activates Transcription Factor NF-κB through the Interleukin-1 Receptor-dependent Signaling Pathway* , 1999, The Journal of Biological Chemistry.

[98]  B. Krammer,et al.  Activation of macrophage tumoricidal activity by photodynamic treatment in vitro--indirect activation of macrophages by photodynamically killed tumor cells. , 1999, Journal of photochemistry and photobiology. B, Biology.

[99]  J. Levy,et al.  Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes. , 1999, Immunopharmacology.

[100]  Michael R Hamblin,et al.  Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. , 1998, Cancer research.

[101]  A. Oseroff,et al.  Antigen specific and nonspecific modulation of the immune response by aminolevulinic acid based photodynamic therapy. , 1998, Immunopharmacology.

[102]  J. Gołąb,et al.  Effective chemo‐immunotherapy of L1210 leukemia in vivo using interleukin‐12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin , 1998, International journal of cancer.

[103]  M. Korbelik,et al.  Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment. , 1998, Journal of photochemistry and photobiology. B, Biology.

[104]  M Bamberg,et al.  Photodynamic Synovectomy Using Benzoporphyrin Derivative in an Antigen‐induced Arthritis Model for Rheumatoid Arthritis , 1998, Photochemistry and photobiology.

[105]  J. Levy,et al.  Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative. , 1997, Immunopharmacology.

[106]  B. Henderson,et al.  Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. , 1997, Cancer research.

[107]  B. Krammer,et al.  Effect of Photodynamic Pretreatment on the Susceptibility of Murine Tumor Cells To Macrophage Antitumor Mechanisms , 1997, Photochemistry and photobiology.

[108]  W. Sluiter,et al.  Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. , 1997, Cancer research.

[109]  T. Dubbelman,et al.  Decreased expression of HLA class I on ocular melanoma cells following in vitro photodynamic therapy. , 1997, Cancer letters.

[110]  M. Korbelik,et al.  Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer. , 1997, British Journal of Cancer.

[111]  J. Levy,et al.  Transcutaneous Photodynamic Therapy Alters the Development of an Adoptively Transferred Form of Murine Experimental Autoimmune Encephalomyelitis , 1996, Photochemistry and photobiology.

[112]  M. Korbelik,et al.  Induction of tumor immunity by photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.

[113]  C. Tkaczyk,et al.  Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes , 1996, European journal of immunology.

[114]  P. Matzinger,et al.  Is cancer dangerous to the immune system? , 1996, Seminars in immunology.

[115]  J. Krosl,et al.  Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. , 1996, Cancer research.

[116]  N. Brasseur,et al.  Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow. , 1996, Anticancer research.

[117]  H. S. de Bruijn,et al.  Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. , 1996, Cancer research.

[118]  G. Kuhnle,et al.  Effects of photodynamic therapy on leucocyte-endothelium interaction: differences between normal and tumour tissue. , 1995, British Journal of Cancer.

[119]  A. Goetz,et al.  Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding. , 1995, Cancer research.

[120]  J. Levy,et al.  SENSITIVITY OF ACTIVATED MURINE PERITONEAL MACROPHAGES TO PHOTODYNAMIC KILLING WITH BENZOPORPHYRIN DERIVATIVE , 1995, Photochemistry and photobiology.

[121]  M. Korbelik,et al.  Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. , 1995, British Journal of Cancer.

[122]  A. Ho,et al.  The use of photodynamic therapy in bone marrow purging. , 1994, Seminars in oncology.

[123]  Mladen Korbelik,et al.  ENHANCED MACROPHAGE CYTOTOXICITY AGAINST TUMOR CELLS TREATED WITH PHOTODYNAMIC THERAPY , 1994, Photochemistry and photobiology.

[124]  M. Korbelik,et al.  Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG). , 1994, Cancer letters.

[125]  Paola Taroni,et al.  Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light , 1994, Anti-cancer drugs.

[126]  J D Waterfield,et al.  The use of transcutaneous photodynamic therapy in the prevention of adjuvant-enhanced arthritis in MRL/lpr mice. , 1994, Clinical immunology and immunopathology.

[127]  D. Metzger,et al.  ENHANCED SKIN ALLOGRAFT SURVIVAL AFTER PHOTODYNAMIC THERAPY: ASSOCIATION WITH LYMPHOCYTE INACTIVATION AND MACROPHAGE STIMULATION1 , 1993, Transplantation.

[128]  T. Wieman,et al.  THE EFFECTS OF THROMBOXANE INHIBITORS ON THE MICROVASCULAR AND TUMOR RESPONSE TO PHOTODYNAMIC THERAPY , 1993, Photochemistry and photobiology.

[129]  M. Colombo,et al.  Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma , 1993, The Journal of experimental medicine.

[130]  W. Star,et al.  Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas. , 1993, Cancer research.

[131]  P B Cerrito,et al.  The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. , 1992, Cancer research.

[132]  N. Yamamoto,et al.  TUMORICIDAL CAPACITIES OF MACROPHAGES PHOTODYNAMICALLY ACTIVATED WITH HEMATOPORPHYRIN DERIVATIVE , 1992, Photochemistry and photobiology.

[133]  R. Fiel,et al.  CUTANEOUS PHOTOSENSITIZING AND IMMUNOSUPPRESSIVE EFFECTS OF A SERIES OF TUMOR LOCALIZING PORPHYRINS , 1991, Photochemistry and photobiology.

[134]  D. Bellnier.  Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factors-α , 1991 .

[135]  D. Bellnier.  Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-alpha. , 1991, Journal of photochemistry and photobiology. B, Biology.

[136]  J K Hoober,et al.  Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light. , 1991, European journal of cancer.

[137]  C. Gomer,et al.  Systemic toxicity in mice induced by localized porphyrin photodynamic therapy. , 1990, Cancer research.

[138]  J. Norton,et al.  Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. , 1990, Journal of the National Cancer Institute.

[139]  C. Elmets,et al.  Inhibition of the high affinity Fc receptor (Fc gamma RI) on human monocytes by porphyrin photosensitization is highly specific and mediated by the generation of superoxide radicals. , 1989, The Journal of biological chemistry.

[140]  R. Straight,et al.  SYSTEMIC IMMUNOSUPPRESSION INDUCED BY PHOTODYNAMIC THERAPY (PDT) IS ADOPTIVELY TRANSFERRED BY MACROPHAGES , 1989, Photochemistry and photobiology.

[141]  B. Lau,et al.  Modulation of hematoporphyrin derivative-sensitized phototherapy with corynebacterium parvum in murine transitional cell carcinoma. , 1989, Urology.

[142]  R. Straight,et al.  Systemic immunosuppression induced by peritoneal photodynamic therapy. , 1988, American journal of obstetrics and gynecology.

[143]  R. von Baehr,et al.  Inhibition of HLA-DR antigen expression and of the allogeneic mixed leukocyte reaction by photochemical treatment. , 2008, Tissue antigens.

[144]  C. Elmets,et al.  Immunological suppression in mice treated with hematoporphyrin derivative photoradiation. , 1986, Cancer research.

[145]  R. Grunow,et al.  The Influence of Haematoporphyrin Derivative and Visible Light on Murine Skin Graft Survival, Epidermal Langerhans Cells and Stimulation of the Allogeneic Mixed Leucocyte Reaction , 1985, Scandinavian Journal of Immunology.

[146]  I. Gigli,et al.  Delayed phase of hematoporphyrin-induced phototoxicity: modulation by complement, leukocytes, and antihistamines. , 1985, The Journal of investigative dermatology.

[147]  T. Mang,et al.  Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. , 1985, Cancer research.

[148]  J. Levy,et al.  Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. , 1983, Journal of immunology.